Delivery Order SPE2DB22D2007-SPE2DB25FJ2FX

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,147.68 firm-fixed-price contract is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of August 22, 2024 and was awarded on August 21, 2022. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of AMNESTEEM 40 MG CAPSULE 30S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a firm fixed price delivery order with a ceiling value of $4,742.72 and a completion date of March 22, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $4,928.16 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 2, 2024. This award is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC, which was awarded solely to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,024.93 Delivery Order is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical for delivering a range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,421.79 firm fixed-price delivery order is for the supply of 4565318071 AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of August 2, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds several Indefinite...
This contract award to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, is for the delivery of AMNESTEEM 40 MG CAPSULE 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price delivery order with a ceiling value of $1,528.61 and a completion date of July 29, 2024. This award is not associated with any set-aside program. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
This is a $2,003.83 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through May 22, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,259.68 firm fixed-price delivery order is for the supply of 4566522024 units of the pharmaceutical product AMNESTEEM 20 MG CAPSULE 30S. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,457.70 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 22, 2024 with a completion date of November 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,011.58 firm fixed-price delivery order is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ2FX
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,676.64 firm fixed-price delivery order is for the supply of 4568518479 ! AMNESTEEM 20 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order is not designated as a set-aside contract.

Generated 9/14/25, 12:46 AM